Risk factors with the development of infection with tigecycline- and carbapenem-resistant Enterobacter cloacae

BACKGROUND: Tigecycline is regarded as a last resort treatment for carbapenem-resistant Enterobacter cloacae (CREC) infections, and increasing numbers of tigecycline- and carbapenem-resistant E. cloacae (TCREC) isolates have been reported in recent years. However, risk factors and clinical impacts o...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yuansu, Jia, Xiaojiong, Xia, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430992/
https://www.ncbi.nlm.nih.gov/pubmed/30936728
http://dx.doi.org/10.2147/IDR.S189941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430992/
https://www.ncbi.nlm.nih.gov/pubmed/30936728
http://dx.doi.org/10.2147/IDR.S189941

Ejemplares similares